Now that 2018 is nearing an end, it is a serious time for investors to start thinking about expectations in 2019 rather than looking back at how choppy 2018 has been.
These 10 companies that are likely to have safer business models and will offer some defensive positioning if the economic strength of 2018 is not repeated in 2019.
Johnson & Johnson reported better-than-expected third-quarter financial results before the markets opened on Thursday.
Chris Lange Johnson & Johnson is scheduled to report its third-quarter financial results early Tuesday, and analysts expect solid growth on the top and bottom lines.
Chris Lange 24/7 Wall St. has put together a preview of Johnson & Johnson, Procter & Gamble and the other Dow Jones industrial average companies scheduled to report their quarterly results this week.
Arrowhead Pharmaceuticals shares stumbled on Thursday after it announced a license and collaboration agreement with Janssen Pharmaceutica, a subsidiary of Johnson & Johnson.
Chris Lange Intel, UnitedHealth, Johnson & Johnson, and 3M Company led the Dow's Tuesday drop.
Trading in the Dow 30 stocks was essentially flat Wednesday with Visa and Microsoft the leading losers while Caterpillar and Johnson & Johnson gained the most.
Nike, Johnson & Johnson, Merck, and Home Depot were Monday's leading gainers.
The more recent observations about Buffett's portfolio changes coming into mid-2018 have been quite different than many of the historic and traditional Buffett picks.
It may not happen overnight, and a solid market correction would almost certainly interfere, but there are many companies that may be chasing that $1 trillion milestone.
The success of Apple has hidden a multitude of problems within the larger market. Can the market hold on to the extraordinary gains it has made in nearly a decade?
United Technologies, Chevron, Exxon Mobil, and Johnson & Johnson posted the Dow's biggest daily gains Tuesday.
The quest for a U.S. company to reach $1 trillion in market capitalization continues, with Apple last seen leading the charge. How are the top 10 U.S. companies faring in the race?
Four pharmaceutical industry leaders are poised to report second-quarter results next week, and one key analyst sees the relatively good print from Johnson & Johnson as a good signal for the group…
